This inventor holds 2 USPTO granted patents. Top assignees: The University of Arizona, The University of Texas System. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,055 
2 out of 5,633 
Years Active: 2019-2022
Title: Innovations in Cancer Treatment by Inventor Lu Chen
Introduction
Lu Chen is an accomplished inventor based in Houston, TX (US), known for his significant contributions to cancer research. With a focus on developing innovative treatments, he holds 2 patents that target critical pathways in cancer cells. His work aims to improve therapeutic options for patients, particularly those suffering from aggressive forms of cancer.
Latest Patents
Lu Chen's latest patents include "Inhibitors of GRB2-associated binding protein 1 (GAB1) and methods of treating cancer using the same." This groundbreaking work involves the identification and evaluation of first-in-class potent inhibitors that target GAB1, a protein frequently over-expressed in cancer cells. Through intensive computational modeling, Chen and his team screened five million compounds to understand the structure of the GAB1 pleckstrin homology (PH) domain. The biological evaluation revealed several inhibitors that induced significant conformational changes in the target structure, demonstrating strong selective binding to the GAB1 PH domain. Notably, these inhibitors exhibited potent and tumor-specific cytotoxicity in breast cancer cells, offering promising avenues for cancer therapy, especially for patients with triple-negative breast cancer.
Career Highlights
Lu Chen has made remarkable strides in his career, contributing to the field of cancer research through his innovative approaches. His work has been recognized for its potential impact on treatment strategies, particularly in targeting GAB1 signaling pathways.
Collaborations
Throughout his career, Lu Chen has collaborated with esteemed colleagues, including Emmanuelle J Meuillet and Shuxing Zhang. These partnerships have enhanced the depth and breadth of his research, fostering a collaborative environment that drives innovation.
Conclusion
Lu Chen's contributions to cancer treatment through his innovative patents highlight the importance of targeted therapies in modern medicine. His work not only advances scientific understanding but also offers hope for improved outcomes in cancer care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile